Clinical Trial Update: Post-Trial Access to ATH434 for Patients With Multiple System Atrophy

View source ↗

Summary

Post-trial access update for ATH434 in patients with Multiple System Atrophy, outlining continued access to the investigational therapy after trial completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• ATH434

Snippet

Sponsor: Alterity Therapeutics | Conditions: Multiple System Atrophy | Status: AVAILABLE